Email: info@ijps.in | Mob: +91-9555269393

Submit Manuscript

Abstract

Synthesis, Molecular Docking studies, Anticancer and Anti-Inflammatory Activity of Tetrazole Linked Isoxazolo[5,4-B]Pyridines

K Thirupathaiah

Department of Chemistry, M. V. S. Government Arts and Science College (A), Mahabubnagar – 509001, Telangana, India.

G Satyanarayana Goud

Department of Chemistry, M. V. S. Government Arts and Science College (A), Mahabubnagar – 509001, Telangana, India.

N Venu Gopal

Department of Chemistry, M. V. S. Government Arts and Science College (A), Mahabubnagar – 509001, Telangana, India.

88 - 103
Vol.16, Issue 1, Jul-Dec, 2023
Receiving Date: 2023-08-05
Acceptance Date: 2023-09-27
Publication Date: 2023-10-11
Download PDF

http://doi.org/10.37648/ijps.v16i01.009

Abstract

Objective: A series of tetrazole linked isoxazolo[5,4-b]pyridines were synthesized, and their anticancer, anti-inflammatory activity, and molecular docking studies were evaluated. Methods: The one-pot reaction of 5-amino-3-methylisoxazole 1, substituted aromatic aldehyde 2, and benzoyl acetonitrile 3 in presence of Fecl3 on basic alumina (1:2 equiv.) furnished 3-methyl-4-aryl-6-phenylisoxazolo[5,4-b]pyridine-5-carbonitriles 4. Compounds 4 on reaction with benzyl azides in presence of saturated copper sulfate solution and Cu-turnings in ethanol afforded the title compounds viz., 5-(2-benzyl-2H-tetrazol-5-yl)-3-methyl-4-aryl-6-phenylisoxazolo[5,4-b]pyridines 5a-l. The anticancer activity of the synthesized compounds was determined using MTT assay for in vitro studies, liquid tumor model for in vivo activity. The anti-inflammatory activity and molecular docking studies has been carried out. Results and Discussion: The structures of newly synthesized derivatives were confirmed by IR, 1H, 13C NMR and mass spectrometry. In anticancer activity as well as in anti-inflammatory studies, among all the derivatives 5a-l, 5c, 5d exhibited potent activity against the HeLa, EAC and MCF-7 cell lines. They also demonstrated significant in vitro cyclooxygenase inhibition (COX-1, COX-2) during anti-inflammatory activity. These results very well supported by molecular docking analysis. Conclusions: A new series of tetrazole linked isoxazolo[5,4-b]pyridines were developed and investigated for in vitro and in vivo anticancer activity, anti-inflammatory activity, and molecular docking studies. Compounds 5c, 5d showed promising results in both anticancer and anti-inflammatory assays, and the results are very well supported by molecular docking analysis. These scaffolds, with further structural modification, hold potential candidates for cancer and inflammatory therapeutics.


Keywords: Three-component synthesis; tetrazole linked isoxazolo[5,4-b]pyridines; anticancer agents; anti-inflammatory activity; molecular docking studies; cyclooxygenase inhibition studies.


References
  1. Bray, F., Laversanne, M., Weiderpass, E., Soerjomataram, I. Cancer., 2021, vol. 127, pp. 3029–3030. https://doi.org/10.1002/cncr.33587.
  2. Bach, P. B., Jett, J. R., Pastorino, U., Tockman, M. S., Swensen, S. J., Begg, C. B. JAMA., 2007, vol. 297, pp. 953-961. doi:10.1001/jama.297.9.953
  3. Siegel, R., Naishadham, D., Jemal, A. Cancer statistics, CA: A Cancer Journal for Clinicians., 2013, vol. 63, pp. 11–30. https://doi.org/10.3322/caac.21166.
  4. Gibbs, J. B. Science., 2000, vol. 287, pp. 1969–1973. https://doi.org/10.1126/science.287.5460.1969.
  5. Liu, S., Khan, A. R., Yang, X., Dong, B., Ji, J., Zhai, G. J. Control. Release., 2021, vol. 335, pp. 1–20. https://doi.org/10.1016/j.jconrel.2021.05.012
  6. Elmore, L. W., Greer, S. F., Daniels, E. C., Saxe, C. C., Melner, M. H., Krawiec, G. M., Cance, W. G., & Phelps, W. C. CA Cancer J. Clin., 2020, vol. 71, pp. 107–139. https://doi.org/10.3322/caac.21652.
  7. Hennequin, L. F., Thomas, A. P., Johnstone, C., Stokes, E. S. E., Plé, P. A., Lohmann, J.-J. M., … Lambertvan der Brempt, C. (1999). J. Med. Chem., 1999, vol. 42, pp. 5369–5389. https://doi.org/10.1021/jm990345w.
  8. Mendelsohn, J., Baselga, J. Oncogene., 2000, vol. 19, pp. 6550–6565. https://doi.org/10.1038/sj.onc.1204082.
  9. Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. Signal Transduct. Target. Ther., 2021, vol. 6(1). https://doi.org/10.1038/s41392-021-00658-5.
  10. Kirkby, N. S., Chan, M. V., Zaiss, A. K., Garcia-Vaz, E., Jiao, J., Berglund, L. M., Verdu, E. F., AhmetajShala, B., Wallace, J. L., Herschman, H. R., Gomez, M. F., Mitchell, J. A. Proc. Natl. Acad. Sci., 2015, vol. 113, pp. 434–439. https://doi.org/10.1073/pnas.1517642113.
  11. Diana, P., Carbone, A., Barraja, P., Kelter, G., Fiebig, H.-H., Cirrincione, G. (2010). Bioorg. Med. Chem., 2010, vol. 18, pp. 4524–4529. https://doi.org/10.1016/j.bmc.2010.04.061
  12. Pooja, S., Pernita, D., Gupta, G. K., Mostafa Sahar, I., Simrat, K. Res. J. Chem. Environ., 2018, vol. 22, pp. 73-88.
  13. Shahinshavali, S., Sreenivasulu, R., Guttikonda, V. R., Kolli, D., Rao, M. V. B. Russ. J. Gen. Chem., 2019, vol. 89, pp. 324–329. https://doi.org/10.1134/s1070363219020257.
  14. Burra, S., Voora, V., Rao, Ch. P., Vijay Kumar, P., Kancha, R. K., David Krupadanam, G. L. Bioorg. Med. Chem., 2017, vol. 27, pp. 4314–4318. https://doi.org/10.1016/j.bmcl.2017.08.033.
  15. Shaik, A., Bhandare, R. R., Palleapati, K., Nissankararao, S., Kancharlapalli, V., Shaik, S. Molecules., 2020, vol. 25, pp. 1047. https://doi.org/10.3390/molecules25051047.
  16. Saravanan, G., Alagarsamy, V., & Dineshkumar, P. Arch. Pharm. Res., 2013, vol. 44, pp. 1–11. https://doi.org/10.1007/s12272-013-0262-8.
  17. Hawash, M., Jaradat, N., Bawwab, N., Salem, K., Arafat, H., Hajyousef, Y., Shtayeh, T., Sobuh, S. Heterocycl. Commun., 2021, vol. 27, pp. 133–141. https://doi.org/10.1515/hc-2020-0134
  18. Dhayanithi, V., Shafi, S., S., Kumaran, K., Jai, S., K. R., Ragavan, V., R., Goud, K., Sanath, Kumari, S., N., & Pati, H., N. J. Serb. Chem. Soc., 2011, vol. 76, pp. 165–175. https://doi.org/10.2298/jsc090421001d.
  19. Muralikrishna, S., Raveendrareddy, P., Ravindranath L. K., Harikrishna, S., Jagadeeswara Rao, P. Der. Pharm. Chem., 2013, vol. 5, pp. 87-93.
  20. Ostrovskii, V. A., Koren, A. O. Heterocycles., 2000, vol. 53, pp. 1421-1448.
  21. Mohite, P.B., Bhaskar, V.H. Int. J. Pharmtech. Res., 2011, vol. 3, pp. 1557-1566.
  22. Adamec, J., Waisser, K., Kuneš, J., Kaustová, J. Arch. Pharm., 2005, vol. 338, pp. 385–389. https://doi.org/10.1002/ardp.200400967.
  23. Rajanarendar, E., Thirupathaiah, K., Ramakrishna, S., & Nagaraju, D. Chin. Chem. Lett., 2015, vol. 26, pp. 1511–1513. https://doi.org/10.1016/j.cclet.2015.07.024.
  24. Rajanarendar, E., Ramakrishna, S., Govardhan Reddy, K., Nagaraju, D., Reddy, Y. N. Bioorg. Med. Chem. Lett., 2013, vol. 23, pp. 3954–3958. https://doi.org/10.1016/j.bmcl.2013.04.053.
  25. Rajanarendar, E., Nagi Reddy, M., Rama Krishna, S., Govardhan Reddy, K., Reddy, Y. N., Rajam, M. V. Eur. J. Med. Chem., 2012, vol. 50, pp. 344–349. https://doi.org/10.1016/j.ejmech.2012.02.013
  26. Rajanarendar, E., Thirupathaiah, K., Ramakrishna, S., Nagaraju, D., Kishore, B. J. Heterocycl. Chem., 2016, vol. 54, pp. 889–894. https://doi.org/10.1002/jhet.2650.
  27. Rajanarendar, E., Nagi Reddy, M., Govardhan Reddy, K., Rama Krishna, S. Tetrahedron Lett., 2012, vol. 53, pp. 2909–2913. https://doi.org/10.1016/j.tetlet.2012.04.002
  28. Kakkerla, R., Marri, S., Krishna, M. P. S. M., Molgara, P., Reddy, Y. N. Lett. Org. Chem., 2018, vol. 15, pp. 124-132. https://doi.org/10.2174/1570178614666170623121207.
  29. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., Boyd, M. R. J. Natl. Cancer Inst., 1990, vol. 82, pp. 1107–1112. https://doi.org/10.1093/jnci/82.13.1107
  30. Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., Gray-Goodrich, M., Campbell, H., Mayo, J., Boyd, M. J. Natl. Cancer Inst., 1991, vol. 83, pp. 757–766. https://doi.org/10.1093/jnci/83.11.757.
  31. Segura, J. A., Barbero, L. G., Márquez, J. Immunol. Lett., 2000, vol. 74, pp. 111–115. https://doi.org/10.1016/s0165-2478(00)00208-x.
  32. Shimura, N., Musya, A., Hashimoto, T., Kojima, S., Kubodera, A., Sasaki, T. Nucl. Med. Biol., 2000, vol. 27, pp. 577–580. https://doi.org/10.1016/s0969-8051(00)00131-1.
  33. Hazra, B., Sarkar, R., Bhattacharyya, S., Roy, P. Fitoterapia, 2002, vol. 73, pp. 730–733. https://doi.org/10.1016/s0367-326x(02)00232-0.
  34. Winter, C. A., Risley, E. A., Nuss, G. W. Exp. Biol. Med., 1962, vol. 111, pp. 544–547. https://doi.org/10.3181/00379727-111-27849
  35. Chen, G.-F., & Dong, X.-Y. J. Chem., 2011, vol. 9, pp. 289–293. https://doi.org/10.1155/2012/197174.
  36. Black, W. C., Bayly, C., Belley, M., Chan, C.-C., Charleson, S., Denis, D., Gauthier, J. Y., Gordon, R., Guay, D., Kargman, S., Lau, C. K., Leblanc, Y., Mancini, J., Ouellet, M., Percival, D., Roy, P., Skorey, K., Tagari, P., Vickers, P., … Prasit, P. Bioorg. Med. Chem. Lett., 1996, vol. 6, pp. 725–730. https://doi.org/10.1016/0960- 894x(96)00100-x.
  37. Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., Olson, A. J. J. Comp. Chem., 2009, vol. 30, pp. 2785–2791. https://doi.org/10.1002/jcc.21256.
  38. Daina, A., Michielin, O., Zoete, V. Nucleic Acids Res., 2019, vol. 47, pp. W357–W364. https://doi.org/10.1093/nar/gkz382.
Back
ELANG212
CLAN4D
VIRAL88
viral88 login link alternatif
VIRAL88
ELANG212
SUPERJP
ELANG212
SUPERJP
BOOSTERJP
BOOSTERJP
PAKONG86
winstrike69 link alternatif
BOOSTERJP
WINSTRIKE69
SLOT GACOR
VIRAL4D
WINSTRIKE69
VIRAL88
WINSTRIKE69
viral88
WINSTRIKE69
WINSTRIKE69
CLAN4D
SAMSONBET86
winstrike69
winstreak 69
winstreak69
winstrik69
winstrike 69
winstreak 69 login
linabet69
linabet69
gojekpot
gojekpot